If insulin glargine was prescribed ... Successful completion of a competency-based insulin pen administration checklist and successful demonstration of a mock insulin injection were required ...

Lilly has been instrumental in supplying its API for insulin at a low cost and offering technology transfer to EVA.

By mode of administration, the injectable pens segment accounted for the highest revenue ... it would be launching its ...

Mylan’s hopes of grabbing a slice of the big US market for insulin glargine – the active ingredient in Sanofi’s Lantus blockbuster – have been dealt a blow. The FDA has issued a second ...

Lilly/Boehringer Ingelheim's insulin glargine product will be available in a pre-filled pen and cartridges for a reusable pen. The marketing authorisation for the Alliance's insulin glargine ...